5AM Venture Management’s Cabaletta Bio CABA Stock Holding History

5AM Venture Management’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,064,263	Closed	-$2.19M	–	22
2022 Q2	$2.19M	Hold	2,064,263	–	–	0.54%	20
2022 Q1	$4.19M	Hold	2,064,263	–	–	0.92%	17
2021 Q4	$7.82M	Sell	2,064,263 -295,000	-13%	-$3.15M	1.47%	15
2021 Q3	$28.7M	Sell	2,359,263 -625,000	-21%	-$5.76M	5.83%	8
2021 Q2	$25.7M	Hold	2,984,263	–	–	6.46%	7
2021 Q1	$33.1M	Sell	2,984,263 -387,000	-11%	-$4.73M	5.96%	5
2020 Q4	$42.1M	Sell	3,371,263 -298,000	-8%	-$3.87M	14.17%	4
2020 Q3	$39.8M	Hold	3,669,263	–	–	10.46%	5
2020 Q2	$40.9M	Hold	3,669,263	–	–	8.95%	5
2020 Q1	$26.8M	Hold	3,669,263	–	–	8.29%	5
2019 Q4	$51.3M	Buy	+3,669,263	New	+$43.5M	11.03%	5

Other funds holding CABA

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

5AM Venture Management's CABA Position: Q3 2022 in Review

5AM Venture Management sold out of Cabaletta Bio (CABA) in Q3 2022, closing a stake of 2,064,263 shares — an estimated $2.19M sold.

5AM Venture Management first reported a position in CABA in Q4 2019 and held it in 11 quarters. The position peaked at $51.3M in Q4 2019. 54 funds tracked by Wall St. Rank hold CABA as of Q3 2022.

5AM Venture Management reported no remaining Cabaletta Bio position as of Q3 2022 after selling out during the quarter.
5AM Venture Management sold 2,064,263 Cabaletta Bio shares in Q3 2022, an estimated $2.19M.
5AM Venture Management first reported a position in Cabaletta Bio in Q4 2019 and held it in 11 quarters.
5AM Venture Management's Cabaletta Bio position peaked at $51.3M in Q4 2019.
54 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2022.

Based on 5AM Venture Management's 13F filing for Q3 2022, filed 14 Nov 2022.